Colon Cancer

Duke develops new breed of viral vaccines to battle colon cancer

Published in Cancer Weekly, March 22nd, 2005

Scientists at the Duke Comprehensive Cancer Center are harnessing the natural infectious power of four viruses - vaccinia, fowlpox, adenovirus and alphavirus - to provoke the immune system into battling colon cancer cells that hide below its radar screen.

Viruses have been used to attack cancer before, but never with such force of numbers and intellectual resources as the Duke researchers are mounting against advanced colon cancer.

A $10 million grant from the National Cancer Institute is funding the 5-year research and clinical project, and Duke is drawing upon the unique intellectual resources of two biotechnology companies in its effort to develop...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2005-03-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry